MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7

Biochemical and Biophysical Research Communications

Volumn 469, Issue 3, 2016, Pages 633-638

  Ren, Wei ^a,b   Li, Chan ^b   Duan, Wanli ^b   Du, Shuangkuan ^b   Yang, Fan ^b   Zhou, Jiancheng ^b   Xing, Junping ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cell invasion; Cell proliferation; Frizzled7; miR 613; Prostate cancer

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 613; PROTEIN; PROTEIN FRIZZLED7; UNCLASSIFIED DRUG; FRIZZLED PROTEIN; FZD7 PROTEIN, HUMAN; MIRN613 MICRORNA, HUMAN;

ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; APOPTOSIS; CELL MOTION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FRIZZLED RECEPTORS; HUMANS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84953636405     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.12.054     Document Type: Article

References (37)

1. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J. Clin. 65 2015 5 29
2. Y.F. Zhang, Y.B. Guan, B. Yang, and et al. Prognostic value of Her-2/neu and clinicopathologic factors for evaluating progression and disease-specific death in Chinese men with prostate cancer Chin. Med. J. Engl. 124 2011 4345 4349
3. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
4. J. Winter, S. Jung, S. Keller, and et al. Many roads to maturity: microRNA biogenesis pathways and their regulation Nat. Cell Biol. 11 2009 228 234
5. T. Dalmay, and D.R. Edwards MicroRNAs and the hallmarks of cancer Oncogene 25 2006 6170 6175
6. P.A. Patil, and C. Magi-Galluzzi MicroRNA in prostate cancer: practical aspects Histol. Histopathol. 2015 11647
7. Y.L. Wang, S. Wu, B. Jiang, and et al. Role of MicroRNAs in prostate cancer pathogenesis Clin. Genitourin. Cancer 13 2015 261 270
8. D.P. Turner, and D.K. Watson ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer Expert Rev. Anticancer Ther. 8 2008 33 42
9. M. Abu-Elmagd, C. Garcia-Morales, and G.N. Wheeler Frizzled7 mediates canonical Wnt signaling in neural crest induction Dev. Biol. 298 2006 285 298
10. M. Asad, M.K. Wong, T.Z. Tan, and et al. FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway Cell Death Dis. 5 2014 e1346
11. T. Reya, and H. Clevers Wnt signalling in stem cells and cancer Nature 434 2005 843 850
12. A. Klaus, and W. Birchmeier Wnt signalling and its impact on development and cancer Nat. Rev. Cancer 8 2008 387 398
13. T.D. King, W. Zhang, M.J. Suto, and et al. Frizzled7 as an emerging target for cancer therapy Cell Signal 24 2012 846 851
14. B. Deng, Y. Zhang, S. Zhang, and et al. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7 Tumour Biol. 36 10 2015 8065 8073
15. B. Deng, S. Zhang, Y. Miao, and et al. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines Med. Oncol. 32 2015 102
16. L. Yang, X. Wu, Y. Wang, and et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer Oncogene 30 2011 4437 4446
17. R.M. Kypta, and J. Waxman Wnt/beta-catenin signalling in prostate cancer Nat. Rev. Urol. 9 2012 418 428
18. Y.X. Fang, and W.Q. Gao Roles of microRNAs during prostatic tumorigenesis and tumor progression Oncogene 33 2014 135 147
19. N. Fenderico, A. Casamichele, V. Profumo, and et al. MicroRNA-mediated control of prostate cancer metastasis: implications for the identification of novel biomarkers and therapeutic targets Curr. Med. Chem. 20 2013 1566 1584
20. H. Kirikoshi, H. Sekihara, and M. Katoh Up-regulation of Frizzled-7 (FZD7) in human gastric cancer Int. J. Oncol. 19 2001 111 115
21. H. Kirikoshi, H. Sekihara, and M. Katoh Expression profiles of 10 members of Frizzled gene family in human gastric cancer Int. J. Oncol. 19 2001 767 771
22. P. Merle, M. Kim, M. Herrmann, and et al. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma J. Hepatol. 43 2005 854 862
23. K. Ueno, M. Hiura, Y. Suehiro, and et al. Frizzled-7 as a potential therapeutic target in colorectal cancer Neoplasia 10 2008 697 705
24. P. Merle, S. de la Monte, M. Kim, and et al. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma Gastroenterology 127 2004 1110 1122
25. S.B. Nambotin, L. Lefrancois, X. Sainsily, and et al. Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma J. Hepatol. 54 2011 288 299
26. W. Wei, M.S. Chua, S. Grepper, and et al. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin Mol. Cancer 10 2011 16
27. K. Ueno, S. Hazama, S. Mitomori, and et al. Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells Br. J. Cancer 101 2009 1374 1381
28. N. Pode-Shakked, O. Harari-Steinberg, Y. Haberman-Ziv, and et al. Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target Oncogene 30 2011 1664 1680
29. X. Wen, F.M. Deng, and J. Wang MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer Am. J. Clin. Exp. Urol. 2 2014 219 230
30. H. Zhang, Y. Hao, J. Yang, and et al. Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis Nat. Commun. 2 2011 554
31. Z. Chen, T. Ma, C. Huang, and et al. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/beta-catenin pathway in hepatocellular carcinoma cells Cell Signal 25 2013 2693 2701
32. J. Song, L. Gao, G. Yang, and et al. MiR-199a regulates cell proliferation and survival by targeting FZD7 PLoS One 9 2014 e110074
33. Y. Takahashi, Q. Chen, R.V. Rajala, and et al. MicroRNA-184 modulates canonical Wnt signaling through the regulation of frizzled-7 expression in the retina with ischemia-induced neovascularization FEBS Lett. 589 2015 1143 1149
34. T.Y. Lu, B. Lin, Y. Li, and et al. Overexpression of microRNA-1 promotes cardiomyocyte commitment from human cardiovascular progenitors via suppressing WNT and FGF signaling pathways J. Mol. Cell Cardiol. 63 2013 146 154
35. N. Barker, and H. Clevers Mining the Wnt pathway for cancer therapeutics Nat. Rev. Drug Discov. 5 2006 997 1014
36. D. Douchi, H. Ohtsuka, K. Ariake, and et al. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/beta-catenin signaling pathway Cancer Lett. 365 2015 132 140
37. J. Manzo-Merino, A. Contreras-Paredes, E. Vazquez-Ulloa, and et al. The role of signaling pathways in cervical cancer and molecular therapeutic targets Arch. Med. Res. 45 2014 525 539